Abstract
Upper extremity disability from cerebral palsy (CP) in both children and adults has multiple aspects to the impairment. Increase muscle spasticity and movement disorder are very common and may be predominating symptoms of the impaired limb. It should be noted, however, that these are often combined with muscle contractures, decreased selective motor control, impaired sensibility, and overall ignoring the limb. The topic of upper extremity spasticity has received as much or more attention than lower extremity spasticity in CP. There are multiple mechanisms for assessing spasticity, which is an issue that continues to be unresolved. In addition to spasticity, movement disorders both athetosis and dystonia are relatively common manifestations of the upper extremity impairment. Treatment for upper extremity spasticity includes many different modalities from oral medication, botulinum toxin injection, electrical stimulation, neurectomy, therapy, and transcranial stimulation. Treatment for movement disorders includes oral medication, intrathecal baclofen, and deep brain stimulation. For the whole population of all children with cerebral palsy, approximately 60% have significant upper extremity disability. The vast majority of these are individuals with spasticity; however approximately 20% also report dyskinetic movement disorders in the upper extremity. The goal for this chapter is to define the treatment options for spasticity and movement disorders in the upper extremity of individuals with CP. The risks, complications, and longer-term expectations of these management strategies will also be discussed.
References
Albright AL (1996a) Baclofen in the treatment of cerebral palsy. Neurology 11:77–83. SRC – GoogleScholar
Albright AL (1996b) Intrathecal baclofen in cerebral palsy movement disorders. Neurology 11(Suppl 1):S29–S35. SRC – GoogleScholar
Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy [see comments]. JAMA 265:1418–1422. SRC – GoogleScholar
Aravamuthan BR, Waugh JL (2016) Localization of basal ganglia and thalamic damage in dyskinetic cerebral palsy. Pediatr Neurol 54:11–21
Aree-uea B, Auvichayapat N, Janyacharoen T, Siritaratiwat W, Amatachaya A, Prasertnoo J, Tunkamnerdthai O, Thinkhamrop B, Jensen MP, Auvichayapat P (2014) Reduction of spasticity in cerebral palsy by anodal transcranial direct current stimulation. J Med Assoc Thail 97:954–962
Arner M, Eliasson AC, Nicklasson S, Sommerstein K, Hagglund G (2008) Hand function in cerebral palsy. Report of 367 children in a population-based longitudinal health care program. J Hand Surg [Am] 33:1337–1347
Austin A, Lin JP, Selway R, Ashkan K, Owen T (2017) What parents think and feel about deep brain stimulation in paediatric secondary dystonia including cerebral palsy: a qualitative study of parental decision-making. Eur J Paediatr Neurol 21(1):185–192
Autti-Ramo I, Larsen A, Taimo A, von Wendt L (2001) Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol 8(Suppl 5):136–144
Beck AJ, Gaskill SJ, Marlin AE, J. (1993) Improvement in upper extremity function and trunk control after selective posterior rhizotomy. Am Ther 47:704–707. SRC – GoogleScholar
Ben-Pazi H (2011) Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. J Child Neurol 26:810–816
Buckon CE, Thomas S, Aiona MD, Piatt JH (1996) Sienko assessment of upper-extremity function in children with spastic diplegia before and after selective dorsal rhizotomy. Dev Med Child Neurol 38:967–975. SRC – GoogleScholar
Chin TY, Duncan JA, Johnstone BR, Graham HK (2005) Management of the upper limb in cerebral palsy. J Pediatr Orthop B 14:389–404
Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK (1997) Botulinum toxin A in the hemiplegic upper limb: a double-blind trial [see comments]. Dev Med Child Neurol 39:185–193. SRC – GoogleScholar
De Rinaldis M, Losito L, Gennaro L, Trabacca A (2010) Long-term oral baclofen treatment in a child with cerebral palsy: electroencephalographic changes and clinical adverse effects. J Child Neurol 25:1272–1274
Fehlings D, Rang M, Glazier J, Steele C (2001) Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome. Eur J Neurol 8(Suppl 5):145–149
Fitoussi F, Ilharreborde B, Presedo A, Souchet P, Pennecot GF, Mazda K (2010) Shoulder external rotator selective neurotomy in cerebral palsy: anatomical study and preliminary clinical results. J Pediatr Orthop B 19:71–76
Fletcher NA, Thompson PD, Scadding JW, Marsden CD (1993) Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 56:865–867
Francisco GE (2006) Successful treatment of posttraumatic hemiballismus with intrathecal baclofen therapy. Am J Phys Med Rehabil 85:779–782
Gilmartin R, Bruce D, Storrs BB, J. (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. Neurology 15:71–77. SRC – GoogleScholar
Gooch JL, Patton CP (2004) Combining botulinum toxin and phenol to manage spasticity in children. Arch Phys Med Rehabil 85:1121–1124
Goyal V, Laisram N, Wadhwa RK, Kothari SY (2016) Prospective randomized study of oral diazepam and baclofen on spasticity in cerebral palsy. J Clin Diagn Res 10:RC01–RC05
Gracies JM, Elovic E, McGuire J, Simpson DM, Part I (1997) Traditional pharmacological treatments for spasticity. Local Treat Muscle Nerve Suppl 6:S61–S91. SRC – GoogleScholar
Hagglund G, Wagner P (2008) Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord 9:150
Halpern R, Gillard P, Graham GD, Varon SF, Zorowitz RD (2013) Adherence associated with oral medications in the treatment of spasticity. PM R 5:747–756
Hansel DE, Hansel CR, Shindle MK, Reinhardt EM, Madden L, Levey EB, Johnston MV, Hoon AH Jr (2003) Oral baclofen in cerebral palsy: possible seizure potentiation? Pediatr Neurol 29:203–206
Hoon AH Jr, Freese PO, Reinhardt EM, Wilson MA, Lawrie WT Jr, Harryman SE, Pidcock FS, Johnston MV (2001) Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 25:55–58
Hurvitz EA, Conti GE, Brown SH (2003) Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Arch Phys Med Rehabil 84:444–454
Jan MM (2004) Misdiagnoses in children with dopa-responsive dystonia. Pediatr Neurol 31:298–303
Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D (2010) Development of the hypertonia assessment tool (HAT): a discriminative tool for hypertonia in children. Dev Med Child Neurol 52:e83–e87
Jones MH (1953) What’s new in cerebral palsy. Calif Med 79:357–361
Kamal N, Bhat DP, Carrick E (2006) Dopa-responsive dystonia (Segawa syndrome). Indian Pediatr 43:635–638
Kamper DG, Yasukawa AM, Barrett KM, Gaebler-Spira DJ (2006) Effects of neuromuscular electrical stimulation treatment of cerebral palsy on potential impairment mechanisms: a pilot study. Pediatr Phys Ther 18:31–38
Koy A, Hellmich M, Pauls KA, Marks W, Lin JP, Fricke O, Timmermann L (2013) Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord 28:647–654
Koy A, Pauls KA, Flossdorf P, Becker J, Schonau E, Maarouf M, Liebig T, Fricke O, Fink GR, Timmermann L (2014) Young adults with dyskinetic cerebral palsy improve subjectively on pallidal stimulation, but not in formal dystonia, gait, speech and swallowing testing. Eur Neurol 72:340–348
Loewen P, Steinbok P, Holsti L, MacKay M (1998) Upper extremity performance and self-care skill changes in children with spastic cerebral palsy following selective posterior rhizotomy. Pediatr Neurosurg 29:191–198. SRC – GoogleScholar
Mackey AH, Walt SE, Lobb G, Stott NS (2004) Intraobserver reliability of the modified Tardieu scale in the upper limb of children with hemiplegia. Dev Med Child Neurol 46:267–272
Marks WA, Honeycutt J, Acosta F Jr, Reed M, Bailey L, Pomykal A, Mercer M (2011) Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus. Mov Disord 26:1748–1751
Marks W, Bailey L, Reed M, Pomykal A, Mercer M, Macomber D, Acosta F Jr, Honeycutt J (2013) Pallidal stimulation in children: comparison between cerebral palsy and DYT1 dystonia. J Child Neurol 28:840–848
Monbaliu E, Ortibus E, Roelens F, Desloovere K, Deklerck J, Prinzie P, de Cock P, Feys H (2010) Rating scales for dystonia in cerebral palsy: reliability and validity. Dev Med Child Neurol 52:570–575
Monbaliu E, De Cock P, Mailleux L, Dan B, Feys H (2017) The relationship of dystonia and choreoathetosis with activity, participation and quality of life in children and youth with dyskinetic cerebral palsy. Eur J Paediatr Neurol 21(2):327-335
Montane E, Vallano A, Laporte JR (2004) Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology 63:1357–1363
Numanoglu A, Gunel MK (2012) Intraobserver reliability of modified Ashworth scale and modified Tardieu scale in the assessment of spasticity in children with cerebral palsy. Acta Orthop Traumatol Turc 46:196–200
Ozer K, Chesher SP, Scheker LR (2006) Neuromuscular electrical stimulation and dynamic bracing for the management of upper-extremity spasticity in children with cerebral palsy. Dev Med Child Neurol 48:559–563
Park HS, Kim J, Damiano DL (2012) Development of a Haptic Elbow Spasticity Simulator (HESS) for improving accuracy and reliability of clinical assessment of spasticity. IEEE Trans Neural Syst Rehabil Eng 20:361–370
Reeuwijk A, van Schie PE, Becher JG, Kwakkel G (2006) Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: a systematic review. Clin Rehabil 20:375–387
Romito LM, Zorzi G, Marras CE, Franzini A, Nardocci N, Albanese A (2015) Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol 22:426–e32
Saintyves G, Genet F, Allieu Y, Judet T, Denormandie P (2011) Surgical management of spasticity of the intrinsic muscles of the long fingers in adults after cerebral palsy, 68 operated hands. Chir Main 30:46–51
Sanger TD, Bastian A, Brunstrom J, Damiano D, Delgado M, Dure L, Gaebler-Spira D, Hoon A, Mink JW, Sherman-Levine S, Welty LJ, Group Child Motor Study (2007) Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 22:530–537
Satila H, Kotamaki A, Koivikko M, Autti-Ramo I (2006) Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Pediatr Rehabil 9:247–258
Speth L, Janssen-Potten Y, Leffers P, Rameckers E, Defesche A, Winkens B, Becher J, Smeets R, Vles JS (2015) Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral cerebral palsy: an explorative study. Eur J Paediatr Neurol 19:337–348
Taira T, Hori T (2007) Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl 97:227–229
Taira T, Hori T (2008) Selective peripheral neurotomy and selective dorsal rhizotomy. Brain Nerve 60:1427–1436
Taira T, Ochiai T, Goto S, Hori T (2006) Fifteen year experience of intrathecal baclofen treatment in Japan. Acta Neurochir Suppl 99:61–63
Valle AC, Dionisio K, Pitskel NB, Pascual-Leone A, Orsati F, Ferreira MJ, Boggio PS, Lima MC, Rigonatti SP, Fregni F (2007) Low and high frequency repetitive transcranial magnetic stimulation for the treatment of spasticity. Dev Med Child Neurol 49:534–538
Van Heest AE, Bagley A, Molitor F, James MA (2015) Tendon transfer surgery in upper-extremity cerebral palsy is more effective than botulinum toxin injections or regular, ongoing therapy. J Bone Joint Surg Am 97:529–536
Wasiak J, Hoare B, Wallen M (2004) Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Cochrane Database Syst Rev: CD003469
Yildizgoren MT, Nakipoglu Yuzer GF, Ekiz T, Ozgirgin N (2014) Effects of neuromuscular electrical stimulation on the wrist and finger flexor spasticity and hand functions in cerebral palsy. Pediatr Neurol 51:360–364
Zancolli EA (2003) Surgical management of the hand in infantile spastic hemiplegia. Hand Clin 19:609–629
Zonta MB, Bruck I, Puppi M, Muzzolon S, Neto Ade C, Coutinho dos Santos LH (2013) Effects of early spasticity treatment on children with hemiplegic cerebral palsy: a preliminary study. Arq Neuropsiquiatr 71:453–461
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Miller, F. (2018). Spasticity, Dystonia, and Athetosis Management in the Upper Extremity in Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-50592-3_110-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-50592-3_110-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50592-3
Online ISBN: 978-3-319-50592-3
eBook Packages: Springer Reference MedicineReference Module Medicine